Pattern recognition receptors in health and diseases

D Li, M Wu - Signal transduction and targeted therapy, 2021 - nature.com
Pattern recognition receptors (PRRs) are a class of receptors that can directly recognize the
specific molecular structures on the surface of pathogens, apoptotic host cells, and damaged …

TLR agonists as vaccine adjuvants targeting cancer and infectious diseases

M Luchner, S Reinke, A Milicic - Pharmaceutics, 2021 - mdpi.com
Modern vaccines have largely shifted from using whole, killed or attenuated pathogens to
being based on subunit components. Since this diminishes immunogenicity, vaccine …

Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial

JD Gunst, JF Højen, MH Pahus, M Rosás-Umbert… - Nature Medicine, 2023 - nature.com
Inducing antiretroviral therapy (ART)-free virological control is a critical step toward a human
immunodeficiency virus type 1 (HIV-1) cure. In this phase 2a, placebo-controlled, double …

Pharmacological modulation of nucleic acid sensors—therapeutic potential and persisting obstacles

C Vanpouille-Box, JA Hoffmann… - Nature reviews Drug …, 2019 - nature.com
Nucleic acid sensors, primarily TLR and RLR family members, as well as cGAS–STING
signalling, play a critical role in the preservation of cellular and organismal homeostasis …

Global spread of SARS-CoV-2 subtype with spike protein mutation D614G is shaped by human genomic variations that regulate expression of TMPRSS2 and MX1 …

C Bhattacharyya, C Das, A Ghosh, AK Singh… - BioRxiv, 2020 - biorxiv.org
COVID-19 pandemic is a major human tragedy. Worldwide, SARS-CoV-2 has already
infected over 3 million and has killed about 230,000 people. SARS-CoV-2 originated in …

The impact of sex on HIV immunopathogenesis and therapeutic interventions

E Mihealsick, A Word, EP Scully - The Journal of Clinical Investigation, 2024 - jci.org
Globally, the majority of people living with HIV are women or girls, but they have been a
minority of participants in clinical trials and observational studies of HIV. Despite this …

The use of toll-like receptor agonists in HIV-1 cure strategies

JT Martinsen, JD Gunst, JF Højen, M Tolstrup… - Frontiers in …, 2020 - frontiersin.org
Toll-like receptors (TLRs) are a family of pattern recognition receptors and part of the first
line of defense against invading microbes. In humans, we know of 10 different TLRs, which …

Effects of 24-week Toll-like receptor 9 agonist treatment in HIV type 1+ individuals

LK Vibholm, CV Konrad, MH Schleimann, G Frattari… - Aids, 2019 - journals.lww.com
Design: This was an exploratory, single-arm clinical trial that tested the immune
enhancement effects of 24-weeks of Toll-like receptor 9 (TLR9) agonist (MGN1703; …

Targeting cellular and tissue HIV reservoirs with toll-like receptor agonists

AB Macedo, CL Novis, A Bosque - Frontiers in immunology, 2019 - frontiersin.org
The elimination of both cellular and tissue latent reservoirs is a challenge toward a
successful HIV cure.“Shock and Kill” are among the therapeutic strategies that have been …

Interactions between toll‐like receptors signaling pathway and gut microbiota in host homeostasis

L Chen, L Zhang, H Hua, L Liu, Y Mao… - Immunity, Inflammation …, 2024 - Wiley Online Library
Abstract Background Toll‐like receptors (TLRs) are a family of fundamental pattern
recognition receptors in the innate immune system, constituting the first line of defense …